Dovrolis, N.; Michalopoulos, G.; Theodoropoulos, G.E.; Arvanitidis, K.; Kolios, G.; Sechi, L.A.; Eliopoulos, A.G.; Gazouli, M.
The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases. Microorganisms 2020, 8, 438.
https://doi.org/10.3390/microorganisms8030438
AMA Style
Dovrolis N, Michalopoulos G, Theodoropoulos GE, Arvanitidis K, Kolios G, Sechi LA, Eliopoulos AG, Gazouli M.
The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases. Microorganisms. 2020; 8(3):438.
https://doi.org/10.3390/microorganisms8030438
Chicago/Turabian Style
Dovrolis, Nikolas, George Michalopoulos, George E. Theodoropoulos, Kostantinos Arvanitidis, George Kolios, Leonardo A. Sechi, Aristidis G. Eliopoulos, and Maria Gazouli.
2020. "The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases" Microorganisms 8, no. 3: 438.
https://doi.org/10.3390/microorganisms8030438
APA Style
Dovrolis, N., Michalopoulos, G., Theodoropoulos, G. E., Arvanitidis, K., Kolios, G., Sechi, L. A., Eliopoulos, A. G., & Gazouli, M.
(2020). The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases. Microorganisms, 8(3), 438.
https://doi.org/10.3390/microorganisms8030438